Research upends scientific understanding of how anticancer drugs work
Research by UMass Chan Medical School scientists Sharon Cantor, Ph.D., and Jenna M. Whalen, Ph.D., poses a new explanation ...
Former two-term Gov. Jim Edgar diagnosed with pancreatic cancer
The Republican who was Illinois governor throughout the 1990s said he was diagnosed in mid-January and has undergone three ...
Cure Today4h
Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, ...
They were told to get extra breast cancer screenings but got stuck with the bill
Millions of American women are at high risk for breast cancer, but their insurance does not cover the costs of extra screenings.
wglt6h
Jim Edgar hopes to beat pancreatic cancer: 'But to be very truthful, if it ended tomorrow, I've had a great life.'
The former Illinois governor has been undergoing chemotherapy after a diagnosis last month, he told the Sun-Times. “I’m ...
manilatimes6h
Silexion Therapeutics Announces Completion of Initial Study in Orthotopic Pancreatic Cancer Models Evaluating Systemic Administration of SIL-204
Silexion Completes Data Collection Phase in First-Ever Evaluation of SIL-204 in Clinically Relevant Orthotopic Models; ...
manilatimes6h
AIM Doses First New Subject in Phase 2 Study of Ampligen and Imfinzi as a Potential Combination Therapy for Late-Stage Pancreatic Cancer
DURIPANC is an investigator-initiated, exploratory, open-label, single-center study in the Netherlands at the Erasmus Medical ...
Genetic testing for cancer should be the norm now, experts say. Here’s when to request it.
Testing is recommended for those with personal and family histories of several types of cancer — including pancreatic and ...
WPBF6h
Pancreatic cancer walk raising awareness
This weekend, the Lustgarten Foundation is hosting a walk to raise awareness about pancreatic cancer. Click here to see how ...
Candel Therapeutics stock rises on positive trial data
Shares of Candel Therapeutics , Inc. (NASDAQ: CADL) climbed 8% following the announcement of favorable final survival data from their phase 2 trial of CAN-2409, a treatment for pancreatic cancer. The ...
Scientists find promising pancreatic cancer leads
Pancreatic cancer kills three in four people within the first year. But new research is offering hope to people in years to ...
With cancer rates rising in young adults, is genetic testing right for you?
For millennials and Gen Z, cancer is no longer rare. Once considered something people get as they grow older, it’s become a harsh reality for younger generations. As cancer ...